Recruiting
Early Phase 1

Does Treatment of Androgen Excess Using Spironolactone Improve Ovulatory Rates in Girls With Androgen Excess?

Sponsor:

University of Virginia

Code:

NCT04075149

Conditions

Polycystic Ovary Syndrome

Puberty Disorders

Ovulation Disorder

Eligibility Criteria

Sex: Female

Age: 13 - 19

Healthy Volunteers: Not accepted

Interventions

Spironolactone

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information